| Literature DB >> 18820982 |
Taco J Blokhuis1, Jan Paul M Frölke.
Abstract
UNLABELLED: Heterotopic ossification is a well-known complication after fixation of an acetabular fracture. Indomethacin and radiation therapy are used as prophylaxis to prevent heterotopic ossification. It is unclear, however, whether either is superior, although this may relate to lack of power in individual studies. To compare the effectiveness of indomethacin with the effectiveness of radiation therapy, we conducted a systematic review in which all published prospective studies were evaluated. We performed a literature search in PubMed, MEDLINE, EMBASE, and the Cochrane Controlled Trial Register. The retrieved studies were analyzed and categorized according to the quality and validity score of Jadad et al. We found five appropriate prospective studies, describing 384 patients. Although the quality of the available studies made a proper meta-analysis inappropriate, the incidence of heterotopic ossification was significantly lower in patients treated with radiation than in patients receiving indomethacin (five of 160 versus 20 of 224, respectively). Until further information is available, we believe the evidence supports radiation therapy as the preferred method for preventing heterotopic ossification after operative treatment of acetabular fractures. LEVEL OF EVIDENCE: Level II, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18820982 PMCID: PMC2628498 DOI: 10.1007/s11999-008-0532-9
Source DB: PubMed Journal: Clin Orthop Relat Res ISSN: 0009-921X Impact factor: 4.176
Fig. 1A flowchart illustrates the method of retrieval of articles and the decision making regarding acceptance or rejection of articles. Search terms are given in the text.
Description of the assessment of validity and quality of articles according to Jadad et al. [14]
| Method | Assessment | Score* |
|---|---|---|
| Randomization | A method to generate the sequence of randomization will be regarded as appropriate if it allowed each study participant to have the same chance of receiving each intervention and the investigators could not predict which treatment was next. | 1 point |
| If the method to generate the sequence of randomization was described and it was appropriate (table of random numbers, computer generated, etc) | Add 1 point | |
| If the method to generate the sequence of randomization was described and it was inappropriate (patients were allocated alternately, or according to date of birth, date of admission, or hospital number, etc) | Deduct 1 point | |
| Double blinding | A study must be regarded as double blind if the word “double blind” is used. The method will be regarded as appropriate if it is stated that neither the person doing the assessments nor the study participant could identify the intervention being assessed, or if in the absence of such a statement the use of active placebos, identical placebos, or dummies is mentioned | 1 point |
| If the method of double blinding was described and it was appropriate (identical placebo, active placebo, dummy, etc) | Add 1 point | |
| If the study was described as double blind, but the method of blinding was inappropriate (eg, comparison of tablet versus injection with no double dummy) | Deduct 1 point | |
| Withdrawals and dropouts | Participants who were included in the study but did not complete the observation period or who were not included in the analysis must be described. The number and the reasons for withdrawal in each group must be stated. If there were no withdrawals, it should be stated in the article. If there is no statement on withdrawals, this item must be given no points | 1 point |
| Total score | 0–5 points | |
* The minimum score is 0 (poor quality, significant flaws in design or conduct of trial); the maximum score is 5. (Reprinted from Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12, copyright © 1996, with permission from Elsevier.)
Characteristics of included studies
| Study (year) | Number of patients | Randomization | Double blinding | Description of withdrawals/ dropouts | Validity score (Jadad et al. [ | ||
|---|---|---|---|---|---|---|---|
| Indomethacin | Radiation therapy | Control | |||||
| Burd et al. [ | 72 | 78 | Yes, inappropriate | No | Yes | 2 | |
| Childs et al. [ | 82 | No | No | No | 0 | ||
| Matta and Siebenrock [ | 61 | 46 | Yes, inappropriate | No | No | 1 | |
| Karunakar et al. [ | 63 | 64 | Yes, appropriate | Yes | No | 3 | |
| Iotov [ | 28 | 24 | No | No | No | 0 | |
| Total | 224 | 160 | 134 | ||||